The pros and cons of MRI and PET-CT for assessing response in multiple myeloma

Evangelos Terpos, MD, PhD, from the University of Athens, Athens, Greece discusses the limitations and challenges associated with using various imaging techniques to assess disease response in multiple myeloma (MM). According to Dr Terpos, with MRI it is possible to decide which patients to treat at diagnosis based on focal lesions while the PET-CT has the advantage of being able to better depict the living cells. Dr Terpos further discusses the benefits of diffusion weighted imaging MRI.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.